Silco Pharmaceuticals Limited (DSE:SILCOPHL)
20.20
-0.30 (-1.46%)
At close: Aug 13, 2026
Silco Pharmaceuticals Market Cap
Silco Pharmaceuticals has a market cap or net worth of 2.1 billion as of August 14, 2026. Its market cap has increased by 31.17% in one year.
Market Cap
2.10B
Enterprise Value
2.07B
Revenue
408.71M
Ranking
n/a
PE Ratio
61.05
Stock Price
20.20
ChartMarket Cap Chart
Since June 13, 2019, Silco Pharmaceuticals's market cap has decreased from 2.37B to 2.10B, a decrease of -11.47%. That is a compound annual growth rate of -1.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 2.10B | 49.63% |
| Dec 30, 2025 | 1.40B | -15.09% |
| Dec 30, 2024 | 1.65B | -32.05% |
| Dec 28, 2023 | 2.43B | - |
| Dec 29, 2022 | 2.43B | -2.90% |
| Dec 30, 2021 | 2.50B | 0.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 10.03B |
| Navana Pharmaceuticals | 7.45B |
| Orion Pharma | 6.72B |
| Techno Drugs | 5.98B |
| Indo-Bangla Pharmaceuticals | 2.24B |
| Silva Pharmaceuticals | 2.24B |
| Pharma Aids | 1.91B |
| Ambee Pharmaceuticals | 1.90B |